Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dariusz Cepowicz is active.

Publication


Featured researches published by Dariusz Cepowicz.


World Journal of Gastroenterology | 2014

Bax protein may influence the invasion of colorectal cancer

Anna Pryczynicz; Mariusz Gryko; Katarzyna Niewiarowska; Dariusz Cepowicz; Marek Ustymowicz; Andrzej Kemona; Katarzyna Guzińska-Ustymowicz

AIM To evaluate the expression of Bcl-xL, Bak, and Bax proteins in correlation with particular clinico-histopathological parameters, including tumor invasion front, in patients with colorectal cancer. METHODS The expression of these proteins was evaluated with the use of the immunohistochemical method in 50 primary tumors. RESULTS According to observations, a low expression of Bax and Bak proteins is related to the localization of the tumor in the rectum (P < 0.05 and P < 0.05 respectively), which may explain an increased incidence of colorectal cancer in this area. A positive expression of Bax protein also correlates with the presence of cancer cell infiltration to lymph and blood vessels (P < 0.05), which may suggest the participation of this protein in the early stages of colorectal cancer progression. Moreover, a positive expression of Bcl-xL protein correlated with a positive expression of Bak protein. This may suggest a greater participation of Bcl-xL protein in the inhibition of the proapoptotic Bak protein, but not the Bax protein. CONCLUSION Bax protein is probably very significant in the cancerogenesis mechanism in the large intestine.


Folia Histochemica Et Cytobiologica | 2011

Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer

Mariusz Gryko; Katarzyna Guzińska-Ustymowicz; Anna Pryczynicz; Dariusz Cepowicz; Adam Kukliński; Jolanta Czyzewska; Andrzej Kemona; Bogusław Kędra

The studys objective was to assess the expressions of Fas and FasL proteins in gastric cancer in correlation with chosen clinicohistological parameters. Fas and FasL expression was analyzed in 68 patients with gastric cancer, using the immunohistochemical method. The expression of Fas was found to be lower in gastric cancer cells than in healthy mucosa, both in the lining epithelium and in glandular tubes (28% vs. 48% and 44%; p < 0.001). The expression of FasL was also markedly lower in cancer cells than in glandular tubes, yet higher than in the lining epithelium (51% vs. 73% and 14%; p < 0.01). Positive expressions of FasL and Fas were lower in less advanced gastric cancer cells (T1, T2), than in more advanced tumors (T3, T4), but only in the case of FasL was this difference statistically significant (p < 0.05). Our findings seem to confirm the theory of the impact of apoptotic disorders at the level of Fas receptor and FasL protein in the process of gastric cancer formation and growth, which is manifested in the varied expressions of these proteins in gastric cancer and in the normal lining and glandular epithelium of the stomach. However, the lack of significant differences in the expressions of Fas and FasL in correlation to other clinicohistological parameters indicates the existence of mechanisms that have a greater impact on the process of differentiation of gastric cancers. This in our opinion eliminates these proteins as prognostic factors.


Polish Journal of Surgery | 2011

Relationships between insulin-like growth factor i and selected clinico-morphological parameters in colorectal cancer patients.

Adam Kukliński; Zbigniew Kamocki; Dariusz Cepowicz; Mariusz Gryko; Jolanta Czyzewska; Krystyna Pawlak; Bogusław Kędra

UNLABELLED Insulin Like Growth Factor (IGF I) as the one of the strongest growth factors which can affect cancers development including colorectal cancer. IGF I induces processes of the cells growth and division. It regulates cells cycle and inhibits apoptosis. There is limited data about correlation between IGF I and staging of the tumor. The aim of the study was estimation of the clinical usefulness of IGF I concentration in the serum of the patients with colorectal cancer. MATERIAL AND METHODS We have examined 125 individuals with colorectal cancer. The age range was 36 to 92 years. They have been operated in the 2nd Departament of The Gastrointestinal Surgery of the Medical University in Białystok. Serum concentration of the IGF I have been estimated using immunoassay ELISA before and after operation. Correlation between serum level of IGF I and clinicopathologic features: age, gender, localisation of the primary tumor, TNM stage of tumor, histological type and histological grade (G) of the cancer have been estimated. RESULTS Our study revealed statistically significant increased serum concentration of IGF I in patients with locally advanced colorectal cancer (pT3 and pT4) comparing to less advanced (pT2) The investigations showed higher serum concentration of IGF I in patients with poorly differentiated cancers (G3) than in moderately differentiated. Similarly higher serum concentration of IGF I were found in male, in patients older than 60 years and in mucigenous colorectal cancers. CONCLUSIONS Our results indicated that IGF I can be one of the factors of the prognosis in colorectal cancer development.


Pathology Research and Practice | 2014

Expression of apoptotic proteins in human colorectal cancer and metastatic lymph nodes

Anna Sadowska; Halina Car; Anna Pryczynicz; Katarzyna Guzińska-Ustymowicz; Krzysztof Kowal; Dariusz Cepowicz; Bogusław Kędra

PURPOSE The aim of this study was to determine the expression of Bak, Bax, Bcl-2, Bcl-xl and procaspase-3 proteins in colorectal tumor and regional lymph nodes, as well as to investigate the correlation between them and with clinicopathologic parameters. METHODS Expression of the examined proteins was evaluated by immunohistochemical study. RESULTS No significant correlation was revealed between Bcl-2, Bcl-xl, Bak, Bax and procaspase-3 expressions and age, gender, location or size of primary tumor and grade in the main tumor mass or in lymph nodes. Additionally, the only association we found was between Bak protein in primary tumor and in adjacent metastatic lymph nodes. CONCLUSION Bcl-2 protein seems to exert substantial effects prevention of apoptosis in pT3 CRC with positive lymph node involvement, while lower expressions of Bcl-xl proteins suggest that it does not play a significant part in the inhibition of apoptosis.


Advances in Medical Sciences | 2014

High Fas expression in gastric carcinoma cells as a factor correlating with the occurrence of metastases to regional lymph nodes.

Mariusz Gryko; Katarzyna Guzińska-Ustymowicz; Joanna Kiśluk; Dariusz Cepowicz; Andrzej Kemona; Bogusław Kędra

PURPOSE The aim of this study was to evaluate the correlation of the expression of Fas and Fas-L proteins in gastric carcinoma cells on the occurrence of metastases to regional lymph nodes. MATERIAL/METHODS The study included 89 patients treated surgically for gastric carcinoma. The evaluated clinicomorphological parameters were verified based on both histopathological material collected at surgery and intraoperative image. Fas and Fas-L expression was evaluated immunohistochemically in the neoplastic tissue of the removed gastric tumors. RESULTS A statistically significant positive correlation between Fas expression in gastric carcinoma cells and the number of regional lymph nodes affected by metastases was observed (p<0.05). No such correlation was noticed with respect to Fas-L. A statistically significant correlation between the depth of neoplastic infiltration of the stomach wall (T feature) and the number of affected lymph nodes was observed (p<0.05). No statistically significant correlations in the other examined clinicomorphological features and the number of metastatic lymph nodes was observed. CONCLUSION A positive Fas expression correlates with more frequent occurrence of metastases to regional lymph nodes. Determination of this protein expression in cancer cells prior to surgery may be helpful for planning the surgical procedure, especially with respect to the extent of lymph node excision.


Advances in Medical Sciences | 2013

Parenteral nutrition and preOp preparation in prevention of post-operative insulin resistance in gastrointestinal carcinoma.

Konrad Zaręba; M Czygier; Zbigniew Kamocki; Dariusz Cepowicz; Maciej Szmitkowski; Bogusław Kędra

PURPOSE The aim was to compare preventive effect of total parenteral nutrition (TPN) and oral nutrition (preOp) on the perioperative insulin resistance prevention in surgical gastrointestinal cancer patients. MATERIAL/METHODS The study was conducted in a group of 75 elective gastric and large intestine cancer patients. Patients were randomly divided into 3 study groups, 25 patients each: group I (NIL) - no preparations influencing tissue sensitivity to insulin, group II (TPN) - total parenteral nutrition in its preoperative stage and group III (TPN + preOp) parenteral nutrition and preOp in the preoperative phase. RESULTS Immediately after the surgery, no statistically significant differences in insulin resistance level between groups were observed. During the first 6 postoperative hours, a statistically significant decrease of insulin resistance level in the TPN+ preOp group in comparison to others, was observed. During the first 24 postoperative hours, the NIL group was the only one to keep the insulin resistance level the same as in the preoperative phase. CONCLUSIONS Application of TPN in the preoperative phase leads to shortening of perioperative insulin resistance time. Combining TPN with oral application of carbohydrate before surgical procedure is an effective and the best method in postoperative insulin resistance syndrome prevention.


Pharmacological Reports | 2012

Increased concentration of metronidazole and its hydroxy metabolite in colon cancer in women.

Anna Sadowska; Bogusław Kędra; Dariusz Cepowicz; Lech Rodziewicz; Anna Fiedorowicz; Wojciech Miltyk; Halina Car

BACKGROUND Metronidazole (MTZ) is indicated in the prevention of infections during surgical procedures. However, some data have shown that metronidazole has carcinogenic potential. METHODS In the present work, we determined concentrations of metronidazole and its hydroxy metabolite (MTZOH) in colorectal cancer patients. MTZ and MTZOH were measured in tumor tissue and surrounding healthy tissue by LC-ESI-MS-MS method. RESULTS We found different concentration of MTZ and MTZOH in colorectal cancer and healthy tissue. Interestingly, we noted a higher level of the above substances in women vs. men, both in healthy and cancerous gut. CONCLUSION We suggest that women are more exposed to a potential carcinogenic effect of metronidazole than men.


Polish Journal of Surgery | 2017

Large pancreatic pseudocyst penetrating into posterior mediastinum

Adam Roman Markowski; Elżbieta Brodalka; Katarzyna Guzińska-Ustymowicz; Konrad Zaręba; Dariusz Cepowicz; Bogusław Kędra

We report a rare case of a large mediastinal pancreatic pseudocyst compressing the left atrium and the esophagus and causing dyspnea, palpitations, and emesis. Chest radiograph was non-diagnostic, esophagogastroduodenoscopy showed diffuse extrinsic compression of the distal esophagus and gastric corpus, but a definitive diagnosis was confirmed by computed tomography. We decided to perform surgery due to the recurrence of the pancreatic pseudocyst, a history of unsuccessful radiologically guided external drainage a few years earlier, and a very large diameter of the pseudocyst causing acute cardio-pulmonary distress syndrome.


Gastroenterology Research and Practice | 2016

Dysfunctions in the Mature Dendritic Cells Are Associated with the Presence of Metastases of Colorectal Cancer in the Surrounding Lymph Nodes

Anna Pryczynicz; Dariusz Cepowicz; Konrad Zaręba; Mariusz Gryko; Joanna Hołody-Zaręba; Bogusław Kędra; Andrzej Kemona; Katarzyna Guzińska-Ustymowicz

Dendritic cells play a key role in the antigen presentation and T cell activation. The aim of this study was a detailed analysis of the presence of mature dendritic cells (CD 83 positive) in colorectal cancer in correlation with selected clinicopathological parameters. The presence of mature dendritic cells (mDCs) was determined immunohistochemically using the anti-CD83 antibody. The morphometric analysis of the mDCs was performed in the normal colon wall adjacent to the cancerous tumor as well as in the front of the tumor and in the main mass of the cancerous tumor. Decrease in mDCs in the front and in the main tumor mass was observed. The increase in the number of mDCs in both of these locations was associated with the presence of metastases in the nearby lymph nodes (p < 0.05 and p < 0.01). Furthermore, the increase in the proportion of mDCs in the main tumor mass was associated with the presence of the invasion of tumor cells into the blood and lymph vessels (p < 0.01). The increase in the amount of mDCs in the cancerous tumor is associated with the invasiveness of the tumor and especially with the metastasis to the surrounding lymph nodes.


Polish Journal of Surgery | 2011

Assessment of Activity of an Adhesion Molecule CD134 and CD137 in Colorectal Cancer Patients

Dariusz Cepowicz; Mariusz Gryko; Konrad Zaręba; Anna Stasiak-Bermuta; Bogusław Kędra

UNLABELLED Epidemiological studies prove that incidence of colorectal cancer is increasing. The first line therapy of colorectal cancer is surgical resection of the primary tumor and elimination of regional and remote metastases. THE AIM OF THE STUDY was to determine expression of adhesion molecules CD134 and CD137 in the peripheral blood in colorectal cancer patients, depending on clinical cancer stage, size and invasion of the tumor. MATERIAL AND METHODS The study enrolled 72 patients with primary colorectal adenocarcinoma. An average patient age was 64.55 years. Clinical tumor stage was assessed using two scales: Dukes: A and Astler-Coller scale. Expression of adhesion molecules was determined in the peripheral blood collected on the day of the procedure and 10 days after the procedure. RESULTS An average activity of CD134 molecules (12.66%) was significantly higher than that of CD137 (6.26%) (p<0.001). Clinical tumor stage was assessed on Dukes scale and was unrelated to CD134 activity, while activity of CD137 was related to clinical cancer stage. CONCLUSIONS CD137 activity is directly proportional to colorectal cancer stage. Surgical resection of the tumor results in increased CD134 and CD137 expression. Long term studies, enrolling larger groups of patients, including their subdivision to colon and rectal cancer, are required to utilize CD134 and CD137 in immune therapy of colorectal cancer.

Collaboration


Dive into the Dariusz Cepowicz's collaboration.

Top Co-Authors

Avatar

Bogusław Kędra

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Anna Pryczynicz

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mariusz Gryko

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Andrzej Kemona

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Konrad Zaręba

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Katarzyna Niewiarowska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Anna Sadowska

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Famulski W

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Halina Car

Medical University of Białystok

View shared research outputs
Researchain Logo
Decentralizing Knowledge